Purchase Short-Term Access

Efficacy and Toxicity of Single Daily Doses of Amikacin and Ceftriaxone versus Multiple Daily Doses of Amikacin and Ceftazidime for Infection in Patients with Cancer and Granulocytopenia
The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
Annals of Internal Medicine 1993;119:584-593. doi:10.7326/0003-4819-119-7_Part_1-199310010-00006

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.